• Find People
  • Campus Map
  • PiratePort
  • A-Z
    • About
    • Submit
    • Browse
    • Login
    View Item 
    •   ScholarShip Home
    • Other Campus Research
    • Open Access
    • View Item
    •   ScholarShip Home
    • Other Campus Research
    • Open Access
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of The ScholarShipCommunities & CollectionsDateAuthorsTitlesSubjectsTypeDate SubmittedThis CollectionDateAuthorsTitlesSubjectsTypeDate Submitted

    My Account

    Login

    Statistics

    View Google Analytics Statistics

    The Multifunctional Protein BAG3: A Novel Therapeutic Target in Cardiovascular Disease

    Thumbnail
    View/ Open
    122.full.pdf (1.660Mb)

    Show full item record
    Author
    Myers, Valerie D.; McClung, Joseph M.; Wang, JuFang; Tahrir, Farzaneh G.; Gupta, Manish K.; Gordon, Jennifer; Kontos, Christopher H.; Khalili, Kamel; Cheung, Joseph Y.; Feldman, Arthur M.
    Abstract
    The B-cell lymphoma 2–associated anthanogene (BAG3) protein is expressed most prominently in the heart, the skeletal muscle, and in many forms of cancer. In the heart, it serves as a co-chaperone with heat shock proteins in facilitating autophagy; binds to B-cell lymphoma 2, resulting in inhibition of apoptosis; attaches actin to the Z disk, providing structural support for the sarcomere; and links the α-adrenergic receptor with the L-type Ca2+ channel. When BAG3 is overexpressed in cancer cells, it facilitates prosurvival pathways that lead to insensitivity to chemotherapy, metastasis, cell migration, and invasiveness. In contrast, in the heart, mutations in BAG3 have been associated with a variety of phenotypes, including both hypertrophic/restrictive and dilated cardiomyopathy. In murine skeletal muscle and vasculature, a mutation in BAG3 leads to critical limb ischemia after femoral artery ligation. An understanding of the biology of BAG3 is relevant because it may provide a therapeutic target in patients with both cardiac and skeletal muscle disease.
    URI
    http://hdl.handle.net/10342/7994
    Date
    2018-02-26
    Citation:
    APA:
    Myers, Valerie D., & McClung, Joseph M., & Wang, JuFang, & Tahrir, Farzaneh G., & Gupta, Manish K., & Gordon, Jennifer, & Kontos, Christopher H., & Khalili, Kamel, & Cheung, Joseph Y., & Feldman, Arthur M.. (February 2018). The Multifunctional Protein BAG3: A Novel Therapeutic Target in Cardiovascular Disease. , (), - . Retrieved from http://hdl.handle.net/10342/7994

    Display/Hide MLA, Chicago and APA citation formats.

    MLA:
    Myers, Valerie D., and McClung, Joseph M., and Wang, JuFang, and Tahrir, Farzaneh G., and Gupta, Manish K., and Gordon, Jennifer, and Kontos, Christopher H., and Khalili, Kamel, and Cheung, Joseph Y., and Feldman, Arthur M.. "The Multifunctional Protein BAG3: A Novel Therapeutic Target in Cardiovascular Disease". . . (), February 2018. November 30, 2023. http://hdl.handle.net/10342/7994.
    Chicago:
    Myers, Valerie D. and McClung, Joseph M. and Wang, JuFang and Tahrir, Farzaneh G. and Gupta, Manish K. and Gordon, Jennifer and Kontos, Christopher H. and Khalili, Kamel and Cheung, Joseph Y. and Feldman, Arthur M., "The Multifunctional Protein BAG3: A Novel Therapeutic Target in Cardiovascular Disease," , no. (February 2018), http://hdl.handle.net/10342/7994 (accessed November 30, 2023).
    AMA:
    Myers, Valerie D., McClung, Joseph M., Wang, JuFang, Tahrir, Farzaneh G., Gupta, Manish K., Gordon, Jennifer, Kontos, Christopher H., Khalili, Kamel, Cheung, Joseph Y., Feldman, Arthur M.. The Multifunctional Protein BAG3: A Novel Therapeutic Target in Cardiovascular Disease. . February 2018; (): . http://hdl.handle.net/10342/7994. Accessed November 30, 2023.
    Collections
    • Open Access

    xmlui.ArtifactBrowser.ItemViewer.elsevier_entitlement

    East Carolina University has created ScholarShip, a digital archive for the scholarly output of the ECU community.

    • About
    • Contact Us
    • Send Feedback